REFERENCES
[1] Georg-Fries, B., Biederlack, S., Wolf, J., zur Hausen, H., Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 1984 , 134 , 64-71.
[2] Atchison, R. W., Casto, B. C., Hammon, W. M., Adenovirus-Associated Defective Virus Particles. Science1965 , 149 , 754-756.
[3] Hoggan, M. D., Blacklow, N. R., Rowe, W. P., Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc. Natl. Acad. Sci. USA 1966 , 55 , 1467-1474.
[4] European Medicines Agency, Assessment Report: Glybera.2012 .
[5] U. S. Food and Drug Administration, Luxturna BL 125610/0 Approval Letter. 2017 .
[6] U. S. Food and Drug Administration, Zolgesma BL 125694/0 Approval Letter. 2019 .
[7] Parks, W. P., Melnick, J. L., Rongey, R., Mayor, H. D., Physical Assay and Growth Cycle Studies of a Defective Adeno-Satellite Virus.J. Virol. 1967 , 1 , 171-180.
[8] Bantel-Schaal, U., Zur Hausen, H., Characterization of the DNA of a defective human parvovirus isolated from a genital site.Virology 1984 , 134 , 52-63.
[9] Rutledge, E. A., Halbert, C. L., Russell, D. W., Infectious Clones and Vectors Derived from Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2. J. Virol. 1998 , 72 , 309-319.
[10] Gao, G. P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., Wilson, J. M., Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA2002 , 99 , 11854-11859.
[11] Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., Wilson, J. M., Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues. J. Virol. 2004 ,78 , 6381-6388.
[12] Mori, S., Wang, L., Takeuchi, T., Kanda, T., Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein. Virology 2004 ,330 , 375-383.
[13] Schmidt, M., Voutetakis, A., Afione, S., Zheng, C., Mandikian, D., Chiorini, J. A., Adeno-Associated Virus Type 12 (AAV12): a Novel AAV Serotype with Sialic Acid- and Heparan Sulfate Proteoglycan-Independent Transduction Activity. J. Virol. 2008 , 82 , 1399-1406.
[14] Schmidt, M., Govindasamy, L., Afione, S., Kaludov, N., Agbandje-McKenna, M., Chiorini, J. A., Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J. Virol.2008 , 82 , 8911-8916.
[15] Srivastava, A., In vivo tissue-tropism of adeno-associated viral vectors. Curr. Opin. Virol. 2016 , 21 , 75-80.
[16] Schober, A. L., Gagarkin, D. A., Chen, Y., Gao, G., Jacobson, L., Mongin, A. A., Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes In vitro and In vivo. Front. Cell. Neurosci. 2016 , 10 , 262.
[17] Sayroo, R., Nolasco, D., Yin, Z., Colon-Cortes, Y., Pandya, M., Ling, C., Aslanidi, G., Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells. Gene Ther.2016 , 23 , 18-25.
[18] Sheppard, H. M., Ussher, J. E., Verdon, D., Chen, J., Taylor, J. A., Dunbar, P. R., Recombinant Adeno-Associated Virus Serotype 6 Efficiently Transduces Primary Human Melanocytes. PLoS One2013 , 8 , e62753.
[19] Blankinship, M. J., Gregorevic, P., Allen, J. M., Harper, S. Q., Harper, H., Halbert, C. L., Miller, D. A., Chamberlain, J. S., Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol. Ther. 2004 ,10 , 671-678.
[20] Wang, Z., Kuhr, C. S., Allen, J. M., Blankinship, M., Gregorevic, P., Chamberlain, J. S., Tapscott, S. J., Storb, R., Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of Immunosuppression.Mol. Ther. 2007 , 15 , 1160-1166.
[21] Qiao, C., Zhang, W., Yuan, Z., Shin, J. H., Li, J., Jayandharan, G. R., Zhong, L., Srivastava, A., Xiao, X., Duan, D., Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Hum. Gene Ther. 2010 , 21 , 1343-1348.
[22] Palomeque, J., Chemaly, E. R., Colosi, P., Wellman, J. A., Zhou, S., Del Monte, F., Hajjar, R. J., Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther.2007 , 14 , 989-997.
[23] Raake, P. W., Hinkel, R., Müller, S., Delker, S., Kreuzpointner, R., Kupatt, C., Katus, H. A., Kleinschmidt, J. A., Boekstegers, P., Müller, O. J., Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther.2008 , 15 , 12-17.
[24] White, J. D., Thesier, D. M., Swain, J. B. D., Katz, M. G., Tomasulo, C., Henderson, A., Wang, L., Yarnall, C., Fargnoli, A., Sumaroka, M., Isidro, A., Petrov, M., Holt, D., Nolen-Walston, R., Koch, W. J., Stedman, H. H., Rabinowitz, J., Bridges, C. R., Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo. Gene Ther. 2011 ,18 , 546-552.
[25] van Lieshout, L. P., Domm, J. M., Rindler, T. N., Frost, K. L., Sorensen, D. L., Medina, S. J., Booth, S. A., Bridges, J. P., Wootton, S. K., A Novel Triple-Mutant AAV6 Capsid Induces Rapid and Potent Transgene Expression in the Muscle and Respiratory Tract of Mice.Mol. Ther. Methods Clin. Dev. 2018 , 9 , 323-329.
[26] Sharma, A., Ghosh, A., Hansen, E. T., Newman, J. M., Mohan, R. R., Transduction efficiency of AAV 2/6, 2/8 and 2/9 vectors for delivering genes in human corneal fibroblasts. Brain Res. Bull.2010 , 81 , 273-278.
[27] Wang, J., DeClercq, J. J., Hayward, S. B., Li, P. W., Shivak, D. A., Gregory, P. D., Lee, G., Holmes, M. C., Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery. Nucleic Acids Res.2015 , 44 , e30.
[28] Rogers, G. L., Huang, C., Clark, R. D. E., Seclén, E., Chen, H.-Y., Cannon, P. M., Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes. Mol. Ther. Methods Clin. Dev. 2021 , 23 , 198-209.
[29] Nawaz, W., Huang, B., Xu, S., Li, Y., Zhu, L., Yiqiao, H., Wu, Z., Wu, X., AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia. Blood Cancer J. 2021 , 11 , 119.
[30] Sather, B. D., Romano Ibarra, G. S., Sommer, K., Curinga, G., Hale, M., Khan, I. F., Singh, S., Song, Y., Gwiazda, K., Sahni, J., Jarjour, J., Astrakhan, A., Wagner, T. A., Scharenberg, A. M., Rawlings, D. J., Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template. Sci. Transl. Med. 2015 , 7 , 307ra156.
[31] Hale, M., Lee, B., Honaker, Y., Leung, W. H., Grier, A. E., Jacobs, H. M., Sommer, K., Sahni, J., Jackson, S. W., Scharenberg, A. M., Astrakhan, A., Rawlings, D. J., Homology-Directed Recombination for Enhanced Engineering of Chimeric Antigen Receptor T Cells. Mol. Ther. Methods Clin. Dev. 2017 , 4 , 192-203.
[32] MacLeod, D. T., Antony, J., Martin, A. J., Moser, R. J., Hekele, A., Wetzel, K. J., Brown, A. E., Triggiano, M. A., Hux, J. A., Pham, C. D., Bartsevich, V. V., Turner, C. A., Lape, J., Kirkland, S., Beard, C. W., Smith, J., Hirsch, M. L., Nicholson, M. G., Jantz, D., McCreedy, B., Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells. Mol. Ther. 2017 , 25 , 949-961.
[33] Eyquem, J., Mansilla-Soto, J., Giavridis, T., van der Stegen, S. J., Hamieh, M., Cunanan, K. M., Odak, A., Gonen, M., Sadelain, M., Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature 2017 , 543 , 113-117.
[34] Dai, X., Park, J. J., Du, Y., Kim, H. R., Wang, G., Errami, Y., Chen, S., One-step generation of modular CAR-T cells with AAV-Cpf1.Nat. Methods 2019 , 16 , 247-254.
[35] Moço, P. D., Aharony, N., Kamen, A., Adeno‐Associated Viral Vectors for Homology‐Directed Generation of CAR‐T Cells.Biotechnol. J. 2020 , 15 , 1900286.
[36] Naeimi Kararoudi, M., Likhite, S., Elmas, E., Yamamoto, K., Schwartz, M., Sorathia, K., de Souza Fernandes Pereira, M., Sezgin, Y., Devine, R. D., Lyberger, J. M., Behbehani, G. K., Chakravarti, N., Moriarity, B. S., Meyer, K., Lee, D. A., Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV.Cell Rep. Methods 2022 .
[37] ClinicalTrials.gov, 2022 .
[38] Au, H. K. E., Isalan, M., Mielcarek, M., Gene Therapy Advances: A Meta-Analysis of AAV Usage in Clinical Settings. Front. Med.2021 , 8 , 809118.
[39] Grimm, D., Kern, A., Rittner, K., Kleinschmidt, J. A., Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum. Gene Ther. 1998 , 9 , 2745-2760.
[40] Xiao, X., Li, J., Samulski, R. J., Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 1998 , 72 , 2224-2232.
[41] Collaco, R. F., Cao, X., Trempe, J. P., A helper virus-free packaging system for recombinant adeno-associated virus vectors.Gene 1999 , 238 , 397-405.
[42] Matsushita, T., Elliger, S., Elliger, C., Podsakoff, G., Villarreal, L., Kurtzman, G., Iwaki, Y., Colosi, P., Adeno-associated virus vectors can be efficiently produced without helper virus.Gene Ther. 1998 , 5 , 938-945.
[43] Wright, J. F., Transient Transfection Methods for Clinical Adeno-Associated Viral Vector Production. Hum. Gene Ther.2009 , 20 , 698-706.
[44] Salabarria, S. M., Nair, J., Clement, N., Smith, B. K., Raben, N., Fuller, D. D., Byrne, B. J., Corti, M., Advancements in AAV-mediated Gene Therapy for Pompe Disease. J. Neuromuscul. Dis.2020 , 7 , 15-31.
[45] Park, J. Y., Lim, B. P., Lee, K., Kim, Y. G., Jo, E. C., Scalable production of adeno-associated virus type 2 vectors via suspension transfection. Biotechnol. Bioeng. 2006 ,94 , 416-430.
[46] Smith, J., Grieger, J., Samulski, R. J., Overcoming Bottlenecks in AAV Manufacturing for Gene Therapy. Cell Gene Ther. Insights2018 , 4 , 815-825.
[47] Chahal, P. S., Schulze, E., Tran, R., Montes, J., Kamen, A. A., Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery.J. Virol. Methods 2014 , 196 , 163-173.
[48] Grieger, J. C., Soltys, S. M., Samulski, R. J., Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector. Mol. Ther. 2016 , 24 , 287-297.
[49] Blessing, D., Vachey, G., Pythoud, C., Rey, M., Padrun, V., Wurm, F. M., Schneider, B. L., Deglon, N., Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells. Mol. Ther. Methods Clin. Dev. 2019 , 13 , 14-26.
[50] Zhao, H., Lee, K. J., Daris, M., Lin, Y., Wolfe, T., Sheng, J., Plewa, C., Wang, S., Meisen, W. H., Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach. Mol. Ther. Methods Clin. Dev. 2020 , 18 , 312-320.
[51] Guan, J.-S., Chen, K., Si, Y., Kim, T., Zhou, Z., Kim, S., Zhou, L., Liu, X., Process Improvement of Adeno-Associated Virus Production. Front. Chem. Eng. 2022 , 4 .
[52] Rajendra, Y., Balasubramanian, S., Hacker, D. L., Large-Scale Transient Transfection of Chinese Hamster Ovary Cells in Suspension,Methods Mol. Biol. , Springer New York 2017 , pp. 45-55.
[53] Bernal, V., Carinhas, N., Yokomizo, A. Y., Carrondo, M. J., Alves, P. M., Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism.Biotechnol. Bioeng. 2009 , 104 , 162-180.
[54] Le Ru, A., Jacob, D., Transfiguracion, J., Ansorge, S., Henry, O., Kamen, A. A., Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine 2010 ,28 , 3661-3671.
[55] Petiot, E., Cuperlovic-Culf, M., Shen, C. F., Kamen, A., Influence of HEK293 metabolism on the production of viral vectors and vaccine. Vaccine 2015 , 33 , 5974-5981.
[56] Joshi, P. R. H., Bernier, A., Moço, P. D., Schrag, J., Chahal, P. S., Kamen, A., Development of a Scalable and Robust Anion-Exchange Chromatographic Method for Enriched Recombinant Adeno-Associated Virus Preparations in Genome Containing Vector Capsids of Serotypes- 5, 6, 8, and 9. Mol. Ther. Methods Clin. Dev. 2021 , 21 , 341-356.
[57] Lock, M., Alvira, M. R., Chen, S. J., Wilson, J. M., Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR. Hum. Gene Ther. Methods 2014 , 25 , 115-125.
[58] Furuta-Hanawa, B., Yamaguchi, T., Uchida, E., Two-Dimensional Droplet Digital PCR as a Tool for Titration and Integrity Evaluation of Recombinant Adeno-Associated Viral Vectors. Hum. Gene Ther. Methods 2019 , 30 , 127-136.
[59] Joshi, P. R. H., Cervera, L., Ahmed, I., Kondratov, O., Zolotukhin, S., Schrag, J., Chahal, P. S., Kamen, A. A., Achieving High-Yield Production of Functional AAV5 Gene Delivery Vectors via Fedbatch in an Insect Cell-One Baculovirus System. Mol. Ther. Methods Clin. Dev. 2019 , 13 , 279-289.
[60] Lins-Austin, B., Patel, S., Mietzsch, M., Brooke, D., Bennett, A., Venkatakrishnan, B., Van Vliet, K., Smith, A. N., Long, J. R., McKenna, R., Potter, M., Byrne, B., Boye, S. L., Bothner, B., Heilbronn, R., Agbandje-Mckenna, M., Adeno-Associated Virus (AAV) Capsid Stability and Liposome Remodeling During Endo/Lysosomal pH Trafficking.Viruses 2020 , 12 , 668.
[61] Ferreira, T. B., Carrondo, M. J., Alves, P. M., Effect of ammonia production on intracellular pH: Consequent effect on adenovirus vector production. J. Biotechnol. 2007 , 129 , 433-438.
[62] Patel, S. D., Papoutsakis, E. T., Winter, J. N., Miller, W. M., The lactate issue revisited: novel feeding protocols to examine inhibition of cell proliferation and glucose metabolism in hematopoietic cell cultures. Biotechnol. Prog. 2000 , 16 , 885-892.
[63] Tran, M. Y., Kamen, A. A., Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.Front. Bioeng. Biotechnol. 2022 , 10 , 887716.
[64] Mendes, J. P., Fernandes, B., Pineda, E., Kudugunti, S., Bransby, M., Gantier, R., Peixoto, C., Alves, P. M., Roldao, A., Silva, R. J. S., AAV process intensification by perfusion bioreaction and integrated clarification. Front. Bioeng. Biotechnol.2022 , 10 , 1020174.
[65] Cervera, L., Gutiérrez-Granados, S., Martínez, M., Blanco, J., Gòdia, F., Segura, M. M., Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium. J. Biotechnol.2013 , 166 , 152-165.
[66] Hildinger, M., Baldi, L., Stettler, M., Wurm, F. M., High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells. Biotechnol. Lett 2007 , 29 , 1713-1721.
[67] Lavado-García, J., Jorge, I., Cervera, L., Vázquez, J., Gòdia, F., Multiplexed Quantitative Proteomic Analysis of HEK293 Provides Insights into Molecular Changes Associated with the Cell Density Effect, Transient Transfection, and Virus-Like Particle Production. J. Proteome Res. 2020 , 19 , 1085-1099.
[68] Dash, S., Sharon, D. M., Mullick, A., Kamen, A. A., Only a small fraction of cells produce assembled capsids during transfection‐based manufacturing of adeno‐associated virus vectors.Biotechnol. Bioeng. 2022 .
[69] Joshi, P. R. H., Venereo‐Sanchez, A., Chahal, P. S., Kamen, A. A., Advancements in molecular design and bioprocessing of recombinant adeno‐associated virus gene delivery vectors using the insect‐cell baculovirus expression platform. Biotechnol. J. 2021 ,16 , 2000021.
[70] Elias, C. B., Zeiser, A., Bédard, C., Kamen, A. A., Enhanced growth of sf-9 cells to a maximum density of 5.2 × 107 cells per mL and production of β-galactosidase at high cell density by fed batch culture.Biotechnol. Bioeng. 2000 , 68 , 381-388.
[71] Meghrous, J., Aucoin, M. G., Jacob, D., Chahal, P. S., Arcand, N., Kamen, A. A., Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor. Biotechnol. Prog.2005 , 21 , 154-160.
[72] Mena, J. A., Aucoin, M. G., Montes, J., Chahal, P. S., Kamen, A. A., Improving adeno-associated vector yield in high density insect cell cultures. J. Gene Med. 2010 , 12 , 157-167.
[73] Bennett, A., Patel, S., Mietzsch, M., Jose, A., Lins-Austin, B., Yu, J. C., Bothner, B., McKenna, R., Agbandje-Mckenna, M., Thermal Stability as a Determinant of AAV Serotype Identity. Mol. Ther. Methods Clin. Dev. 2017 , 6 , 171-182.
[74] Bereiter-Hahn, J., Munnich, A., Woiteneck, P., Dependence of energy metabolism on the density of cells in culture. Cell Struct. Funct. 1998 , 23 , 85-93.
[75] Martinez, V., Gerdtzen, Z. P., Andrews, B. A., Asenjo, J. A., Viral vectors for the treatment of alcoholism: Use of metabolic flux analysis for cell cultivation and vector production. Metab. Eng.2010 , 12 , 129-137.
[76] Shen, C. F., Voyer, R., Tom, R., Kamen, A., Reassessing culture media and critical metabolites that affect adenovirus production.Biotechnol. Prog. 2009 , 26 , NA-NA.
[77] Bosma, B., Du Plessis, F., Ehlert, E., Nijmeijer, B., De Haan, M., Petry, H., Lubelski, J., Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system. Gene Ther. 2018 , 25 , 415-424.
[78] Grieger, J. C., Snowdy, S., Samulski, R. J., Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly. J. Virol. 2006 ,80 , 5199-5210.
[79] Girod, A., Wobus, C. E., Zádori, Z., Ried, M., Leike, K., Tijssen, P., Kleinschmidt, J. A., Hallek, M., The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J. Gen. Virol. 2002 ,83 , 973-978.
[80] Sonntag, F., Bleker, S., Leuchs, B., Fischer, R., Kleinschmidt, J. A., Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J. Virol. 2006 , 80 , 11040-11054.
[81] Venkatakrishnan, B., Yarbrough, J., Domsic, J., Bennett, A., Bothner, B., Kozyreva, O. G., Samulski, R. J., Muzyczka, N., McKenna, R., Agbandje-McKenna, M., Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking. J. Virol. 2013 , 87 , 4974-4984.
[82] Stahnke, S., Lux, K., Uhrig, S., Kreppel, F., Hosel, M., Coutelle, O., Ogris, M., Hallek, M., Buning, H., Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles. Virology 2011 , 409 , 77-83.
[83] Francois, A., Bouzelha, M., Lecomte, E., Broucque, F., Penaud-Budloo, M., Adjali, O., Moullier, P., Blouin, V., Ayuso, E., Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls. Mol. Ther. Methods Clin. Dev. 2018 , 10 , 223-236.
[84] U. S. Food and Drug Administration, Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products. 2011 .